Anatara Lifesciences Ltd
ANR
Company Profile
Business description
Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Its products include the Gastrointestinal ReProgramming dietary supplement (GaRP) for humans and Detach for animals. It generates its income from license revenue.
Contact
c/- Perks, 81 Flinders Street
Level 8
AdelaideSA5000
AUST: +61 438027172
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,920.20 | 358.50 | 4.74% |
| CAC 40 | 6,863.02 | 237.40 | -3.34% |
| DAX 40 | 19,670.88 | 609.38 | -3.00% |
| Dow JONES (US) | 40,205.73 | 340.20 | -0.84% |
| FTSE 100 | 7,679.48 | 231.05 | -2.92% |
| HKSE | 20,818.92 | 554.43 | 2.74% |
| NASDAQ | 16,836.27 | 285.66 | 1.73% |
| Nikkei 225 | 34,353.17 | 2,639.14 | 8.32% |
| NZX 50 Index | 12,203.19 | 396.64 | 3.36% |
| S&P 500 | 5,381.00 | 398.23 | 7.99% |
| S&P/ASX 200 | 7,719.30 | 344.30 | 4.67% |
| SSE Composite Index | 3,221.04 | 34.23 | 1.07% |